Status:

NOT_YET_RECRUITING

The Effectiveness of Telemedicine Monitoring Prehabilitation in Prostate Cancer Patients Undergoing Radical Prostatectomy

Lead Sponsor:

University Hospital Olomouc

Collaborating Sponsors:

Mobilní fyzioterapie s.r.o.

Conditions:

Prostatectomy

Prehabilitation

Eligibility:

MALE

40-80 years

Phase:

NA

Brief Summary

The study titled " The effectiveness of telemedicine monitoring prehabilitation in prostate cancer patients undergoing radical prostatectomy " investigates the impact of a structured telemedicine-supp...

Detailed Description

Participants in the intervention group will receive a comprehensive prehabilitation program starting 30 -14 days before surgery. They will be equipped with wearable devices (smartwatch and tablet/mobi...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Biopsy-confirmed localized prostate cancer (ICD code C.61).
  • Indicated for radical prostatectomy, with or without pelvic lymphadenectomy (ePLND).
  • Not previously treated for prostate cancer, including radiation therapy to the pelvis, major pelvic surgery, or placement of a penile implant or artificial urinary sphincter.
  • No known urethral stricture or colostomy or chronic urinary catheterization.
  • No medical or current psychiatric disorders that precludes their participation in the study.
  • Status of the musculoskeletal system allowing physical exercise.
  • Urinary continent at baseline.
  • Has reliable internet and the skills/knowledge to use technologies use for the study.
  • Exclusion criteria:
  • Other malignant tumors, except for benign skin carcinoma.
  • Active treatment for other oncological diagnoses.
  • Presence of preoperative urinary incontinence.
  • Diagnosed mental or cognitive disorders.
  • Prior pelvic radiotherapy or hormone therapy for prostate cancer recurrence.
  • Severe musculoskeletal disorders preventing active exercise
  • Inability to use required technologies

Exclusion

    Key Trial Info

    Start Date :

    January 1 2026

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 30 2028

    Estimated Enrollment :

    200 Patients enrolled

    Trial Details

    Trial ID

    NCT06981026

    Start Date

    January 1 2026

    End Date

    September 30 2028

    Last Update

    May 20 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Urology clinic, University hospital Olomouc

    Olomouc, Czechia, 77900